Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mamassist is an Israeli medical technology company dedicated to improving breast cancer detection through innovative wearable technology. The company has developed a non-invasive, radiation-free sensor device designed to be worn by women to monitor breast health and detect early physiological changes associated with malignancy. Utilizing advanced thermal sensing technology, the device identifies abnormal heat patterns that may indicate tumor growth, providing a potential screening tool for use between clinical exams. Mamassist aims to empower women with a portable, easy-to-use solution that complements existing diagnostic methods like mammography and ultrasound.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mamassist.